Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Budde

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Research Square|August 6, 2025
Protein-based Diagnosis and Analysis of Co-pathologies Across Neurodegenerative Diseases: Large-Scale AI-Boosted CSF and Plasma ClassificationYing Xu, Daniel Western, Gyujin Heo, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Protein-based Diagnosis and Analysis of Co-pathologies Across Neurodegenerative Diseases: Large-Scale AI-Boosted CSF and Plasma ClassificationYing Xu, Daniel Western, Gyujin Heo, et al.
Research Square|June 19, 2023
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer's diseaseCarlos Cruchaga, Dan Western, Jigyasha Timsina, et al.
Neuron|March 15, 2025
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuumMuhammad Ali, Jigyasha Timsina, Daniel Western, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 28, 2026
GPND-AI NULISA: A 15-Protein AI classifier for diagnosis and co-pathology profiling across neurodegenerative diseasesYing Xu, Marisa N Denkinger, Menghan Liu, et al.
The Lancet. Neurology|May 13, 2026
Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association studyMaulikkumar Patel, Wei Feng, Nicole S Mckay, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 25, 2025
Novel early-onset Alzheimer-associated genes influence risk through dysregulation of glutamate, immune activation, and intracellular signaling pathwaysJoseph Bradley, Cyril Pottier, Eder Lucio da Fonseca, et al.
Neuron|March 31, 2026
Large-scale CSF and plasma proteomics reveal immune, synaptic, and extracellular matrix disruptions across neurodegenerative diseasesMuhammad Ali, Jigyasha Timsina, Ying Xu, et al.
Science Translational Medicine|August 16, 2019
The <i>MS4A</i> gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease riskYuetiva Deming, Fabia Filipello, Francesca Cignarella, et al.
The American Journal of Psychiatry|June 4, 2008
Variants in nicotinic receptors and risk for nicotine dependenceLaura Jean Bierut, Jerry A Stitzel, Jen C Wang, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Research Square|August 6, 2025
Protein-based Diagnosis and Analysis of Co-pathologies Across Neurodegenerative Diseases: Large-Scale AI-Boosted CSF and Plasma ClassificationYing Xu, Daniel Western, Gyujin Heo, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Protein-based Diagnosis and Analysis of Co-pathologies Across Neurodegenerative Diseases: Large-Scale AI-Boosted CSF and Plasma ClassificationYing Xu, Daniel Western, Gyujin Heo, et al.
Research Square|June 19, 2023
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer's diseaseCarlos Cruchaga, Dan Western, Jigyasha Timsina, et al.
Neuron|March 15, 2025
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuumMuhammad Ali, Jigyasha Timsina, Daniel Western, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 28, 2026
GPND-AI NULISA: A 15-Protein AI classifier for diagnosis and co-pathology profiling across neurodegenerative diseasesYing Xu, Marisa N Denkinger, Menghan Liu, et al.
The Lancet. Neurology|May 13, 2026
Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association studyMaulikkumar Patel, Wei Feng, Nicole S Mckay, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 25, 2025
Novel early-onset Alzheimer-associated genes influence risk through dysregulation of glutamate, immune activation, and intracellular signaling pathwaysJoseph Bradley, Cyril Pottier, Eder Lucio da Fonseca, et al.
Neuron|March 31, 2026
Large-scale CSF and plasma proteomics reveal immune, synaptic, and extracellular matrix disruptions across neurodegenerative diseasesMuhammad Ali, Jigyasha Timsina, Ying Xu, et al.
Science Translational Medicine|August 16, 2019
The <i>MS4A</i> gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease riskYuetiva Deming, Fabia Filipello, Francesca Cignarella, et al.
The American Journal of Psychiatry|June 4, 2008
Variants in nicotinic receptors and risk for nicotine dependenceLaura Jean Bierut, Jerry A Stitzel, Jen C Wang, et al.
Pageof 7